— Know what they know.
Not Investment Advice

GTHP OTC

Guided Therapeutics, Inc.
1W: -11.3% 1M: -12.0% 3M: -21.4% YTD: -59.3% 1Y: -18.5% 3Y: +46.7% 5Y: -60.4%
$0.22
-0.03 (-11.25%)
 
Weekly Expected Move ±26.5%
$0 $0 $0 $0 $0
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 52 · $21.2M mcap · 40M float · 0.048% daily turnover · Short 78% of daily vol

Supply Chain Overview

2 relationships
2
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-09-07
Earliest Filing
2022-09-15
Latest Filing
investor: 1 partner: 1

Counterparties (Filed by GTHP)

2 relationships

Companies named in GTHP's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Auctus Funds, LLC — investor Exchanged debt and warrants for new equity investment and received partial repayment. 2022-09-15 View
Shandong Yaohua Medical Instrument Corporation — partner Exclusive global license agreement for LuViva device manufacturing and distribution in China and surrounding regions 2021-09-07 View
Recent 8-K Filings (8)
Filing Date Description Type SEC
2026-03-10 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin Agreement View
2024-12-23 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2022-09-15 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin Agreement View
2022-07-29 Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla View
2022-01-07 Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla View
2021-09-07 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2021-07-27 Submission of Matters to a Vote of Security Holders View
2021-06-10 Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Amendments to Art Agreement View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms